Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin

Journal of Cellular Biochemistry

Volumn 78, Issue 1, 2000, Pages 8-23

  Chang, Pi Ling ^a   Chambers, Ann F ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Anchorage independent growth assay; Cell attachment; Integrin; Mouse epidermal cells; Osteopontin; PMA; Tumorigenesis

Indexed keywords

INTEGRIN; OSTEOPONTIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL TRANSFORMATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY;

ANIMALIA;

EID: 0034096842     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000701)78:1<8::AID-JCB2>3.0.CO;2-S     Document Type: Article

References (52)

1. 3 and phorbol myristate acetate is dependent on osteopontin synthesis and the alpha v beta 3 integrin. Connect Tissue Res 35:163-171.
2. Bayless KJ, Meininger GA, Scholtz M, Davis GE. 1998. Osteopontin is a ligand for the alpha4beta1 integrin. J Cell Science 111:1165-1174.
3. Butler WT. 1991. Sialoproteins of bone and dentin. J Biol Buccale 19:83-89.
4. Chambers AF, Hota C, Prince CW. 1993. Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin. Cancer Res 53:701-706.
5. 3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells. Cancer Res 51:2144-2150.
6. 3 enhances 12-O-tetradecanoylphorbol-13-acetate-induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells. Cancer Res 53: 2217-2220.
7. Cheresh DA, Harper JR. 1987. Arg-Gly-Asp recognition by a cell adhesion receptor requires its 130-kDa α subunit. J Biol Chem 262:1434-1437.
8. Colburn NH, Bruegge WF, Bates JR, Gray RH, Rossen JD, Kelsey WH, Shimada T. 1978. Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res 38:624-634.
9. Colburn NH, Former BF, Nelson KA, Yuspa SH. 1979. Tumor promoter induces anchorage independence irreversibly. Nature (Lond) 281:589-591.
10. Colburn NH, Smith BM, Wendel, EJ, Dowjat WK, Shimada T. 1988. Transfer of pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells. Cancer Res 48:1195-1200.
11. Craig AM, Bowden GT, Chambers AF, Spearman MA, Greenberg AH, Wright JA, McLeod M, Denhardt DT. 1990. Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Int J Cancer 46:133-137.
12. Craig AM, Smith JH, Denhardt DT. 1989. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J Biol Chem 264:9682-9689.
13. Denhardt DT, Guo X. 1993. Osteopontin: a protein with diverse functions. FASEB J 7:1475-1482.
14. D'Errico JA, Sauk JJ, Prince CW, Somerman MJ. 1995. Osteopontin adhesion receptors on gingival fibroblasts. J Periodont Res 30:34-41.
15. Dion LD, Gindhart TD, Colburn NH. 1988. Four-day duration of tumor promoter exposure required to transform JB6 promotion-sensitive cells to anchorage independence. Cancer Res 48:7126-7131.
16. Dong A, Birrer, MJ, Watts RG, Matrisian LM, Colburn NH. 1994. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 91:609-613.
17. Felding-Habermann B, Ruggeri ZM, Cheresh DA. 1992. Distinct biological consequences of integrin alpha v beta 3-mediated melanoma cell adhesion to fibrinogen and its plasmid fragments. J Biol Chem 267:5070-5077.
18. Gaietta G, Redelmeier TE, Jackson MR, Tamura RN, Quaranta V. 1994. Quantitative measurement of alpha 6 beta 1 and alpha 6 beta 4 integrin internalization under cross-linking conditions: a possible role for alpha 6 cytoplasmic domains. J Cell Sci 107:3333-3349.
19. Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M. 1995. Osteopontin expression in cardiovascular diseases. Ann NY Acad Sci 760:109-126.
20. Giachelli CM, Scatena M, Wada T. 1997 Osteopontin: potential roles in vascular function and dystrophyic calcification. J Bone Min Metab 15:179-183.
21. Grano M, Zigrino P, Colucci S, Zambonin G, Trusolino L, Serra M, Baldini N, Teti A, Marchisio PC, Zallone AZ. 1994. Adhesion properties and integrin expression of cultured human osteoclast-like cells. Exp Cell Res 212: 209-218.
22. Hayman EG, Pierschbacher MD, Suzuki S, Ruoslahti E. 1985. Vitronectin - a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res 160:245-258.
23. Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW. 1995. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem 270:26232-26238.
24. Katagiri YU, Murakami M, Mori K, Iizuka J, Hara T, Tanaka K, Jia WY, Chambers AF, Uede T. 1996. Non-RGD domains of osteopontin promote cell adhesion without involving alpha v integrins. J Cell Biochem 62:123-131.
25. Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T. 1999. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of argininie-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 59:219-226.
26. Landegren U. 1984. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Application to detection of lypmphokines and cell surface antigens. J Immunol Methods 67:379-388.
27. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. 1995b. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 95:713-724.
28. Loeser RF. 1993. Integrin-mediated attachment of articular chondrocytes to extracellular matrix proteins. Arthrit Rheum 36:1103-1110.
29. McGarrity GJ, Steiner T, Vanaman V. 1983. Detection of mycoplasma infection of cell cultures by DNA fluorochrome staining. In: Tully JG, Razin E, editors. Methods in mycoplasmology. Volume II. New York: Academic Press. pp 155-208.
30. Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin Zallone A, Ross FP, Teitelbaum SL, Cheresh D, Hruska KA. 1991. Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 266:20369-20374.
31. Nasu K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S. 1995. Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells. Biochem J 307:257-265.
32. Oates AJ, Barraclough R, Rudland PS. 1997. The role of osteopontin in tumorigenesis and metastasis. Invasion Metast 17:1-15.
33. Oldberg A, Franzen A, Heinegard D. 1986. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819-8823.
34. Patarca R, Saavedra RA, Cantor H. 1993. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/ osteopontin gene. Crit Rev Immunol 13:225-246.
35. Prince CW. 1989. Secondary structure predictions for rat osteopontin. Connect Tissue Res 21:15-20.
36. Prince CW, Oosawa T, Butler WT, Tomana M, Bhown AS, Bhown M, Schrohenloher RE. 1987. Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 262:2900-2907.
37. Raub TJ, Kuentzel SL. 1989. Kinetic and morphology evidence for endocytosis of mammalian cell integrin receptors by using an anti-fibronectin receptor beta subunit monoclonal antibody. Exp Cell Res 184:407-426.
38. Reinholt FP, Hultenby K, Oldberg A, Heinegard D. 1990. Osteopontin - a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 87:4473-4475.
39. Rittling SR, Denhardt DT. 1999 Osteopontin function in pathology: lessons form osteopontin-deficient mice. Exp Nephrol 7:103-113.
40. Rittling SR, Novak KE. 1997. Osteopontin expression in mammary gland development and tumorigenesis. Cell Growth Different 8:1061-1069.
41. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA. 1993. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J Biol Chem 268:9901-9907.
42. Senger DR, Asch BB, Smith BD, Perruzzi CA, Dvorak HF. 1983. A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature 302:714-715.
43. Senger DR, Perruzzi CA, Papadopoulos A. 1989. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res 9:1291-1299.
44. Smith JH, Denhardt DT. 1987. Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J Cell Biochem 34:13-22.
45. Smith JH, Denhardt DT. 1989. Evidence for two pathways of protein kinase C induction of 2ar expression: correlation with mitogenesis. J Cell Physiology 139: 189-195.
46. Smith LL, Cheung HK, Ling LE, Chen J, Sheppard D, Pytela R, Giachelli CM. 1996. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. J Biol Chem 271: 28485-28491.
47. Takahashi K, Heine UI, Junker JL, Colburn NH, Rice JM. 1986. Role of cytoskeleton changes and expression of the H-ras oncogene during promotion of neoplastic transformation in mouse epidermal JB6 cells. Cancer Res 46:5923-5932.
48. van Dijk S, D'Errico JA, Somerman MJ, Farach-Carson MC, Butler WT. 1993. Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment. J Bone Min Res 8:1499-1506.
49. Weber GF, Ashkar S, Glimcher MJ, Cantor H. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512.
50. Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF. 1995. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions. J Cell Biochem 57:680-690.
51. Yamada KM. 1983. Cell surface interactions with extracellular materials. Annu Rev Biochem 52:761-799.
52. Zerlauth G, Wolf G. 1985. Release of fibronectin is linked to tumor promotion: response of promotable and non-promotable clones of a mouse epidermal cell line. Carcinogenesis 6:73-78.